VHT holdings
Vanguard Health Care ETF
Positions
407 stored of 407 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 532457108 | 14.045% | $2.7B | Equity (common) | Corporate | United States | USD |
| 2 | Johnson & Johnson | US4781601046 | 478160104 | 8.468% | $1.6B | Equity (common) | Corporate | United States | USD |
| 3 | AbbVie Inc | US00287Y1091 | 00287Y109 | 6.086% | $1.2B | Equity (common) | Corporate | United States | USD |
| 4 | UnitedHealth Group Inc UNITEDHEALTH GRP | US91324P1021 | 91324P102 | 5.449% | $1.0B | Equity (common) | Corporate | United States | USD |
| 5 | Merck & Co Inc | US58933Y1055 | 58933Y105 | 4.661% | $885.0M | Equity (common) | Corporate | United States | USD |
| 6 | Thermo Fisher Scientific Inc | US8835561023 | 883556102 | 2.927% | $555.7M | Equity (common) | Corporate | United States | USD |
| 7 | Amgen Inc | US0311621009 | 031162100 | 2.868% | $544.7M | Equity (common) | Corporate | United States | USD |
| 8 | Gilead Sciences Inc | US3755581036 | 375558103 | 2.638% | $500.9M | Equity (common) | Corporate | United States | USD |
| 9 | Intuitive Surgical Inc | US46120E6023 | 46120E602 | 2.381% | $452.1M | Equity (common) | Corporate | United States | USD |
| 10 | Pfizer Inc | US7170811035 | 717081103 | 2.354% | $447.0M | Equity (common) | Corporate | United States | USD |
| 11 | Abbott Laboratories ABBOTT LABS | US0028241000 | 002824100 | 2.354% | $447.0M | Equity (common) | Corporate | United States | USD |
| 12 | Bristol-Myers Squibb Co BRISTOL-MYER SQB | US1101221083 | 110122108 | 1.841% | $349.6M | Equity (common) | Corporate | United States | USD |
| 13 | Danaher Corp | US2358511028 | 235851102 | 1.837% | $348.7M | Equity (common) | Corporate | United States | USD |
| 14 | CVS Health Corp | US1266501006 | 126650100 | 1.827% | $346.9M | Equity (common) | Corporate | United States | USD |
| 15 | Vertex Pharmaceuticals Inc | US92532F1003 | 92532F100 | 1.796% | $341.1M | Equity (common) | Corporate | United States | USD |
| 16 | Stryker Corp | US8636671013 | 863667101 | 1.661% | $315.3M | Equity (common) | Corporate | United States | USD |
| 17 | Medtronic PLC | IE00BTN1Y115 | G5960L103 | 1.496% | $284.1M | Equity (common) | Corporate | United States | USD |
| 18 | McKesson Corp | US58155Q1031 | 58155Q103 | 1.449% | $275.2M | Equity (common) | Corporate | United States | USD |
| 19 | Elevance Health Inc | US0367521038 | 036752103 | 1.352% | $256.8M | Equity (common) | Corporate | United States | USD |
| 20 | Cigna Group/The THE CIGNA GROUP | US1255231003 | 125523100 | 1.172% | $222.6M | Equity (common) | Corporate | United States | USD |
| 21 | Boston Scientific Corp BOSTON SCIENTIFC | US1011371077 | 101137107 | 1.133% | $215.1M | Equity (common) | Corporate | United States | USD |
| 22 | Regeneron Pharmaceuticals Inc | US75886F1075 | 75886F107 | 1.004% | $190.7M | Equity (common) | Corporate | United States | USD |
| 23 | HCA Healthcare Inc | US40412C1018 | 40412C101 | 0.956% | $181.6M | Equity (common) | Corporate | United States | USD |
| 24 | Edwards Lifesciences Corp | US28176E1082 | 28176E108 | 0.794% | $150.7M | Equity (common) | Corporate | United States | USD |
| 25 | Cencora Inc | US03073E1055 | 03073E105 | 0.785% | $149.1M | Equity (common) | Corporate | United States | USD |
| 26 | Cardinal Health Inc | US14149Y1082 | 14149Y108 | 0.739% | $140.4M | Equity (common) | Corporate | United States | USD |
| 27 | IDEXX Laboratories Inc IDEXX LABS | US45168D1046 | 45168D104 | 0.712% | $135.2M | Equity (common) | Corporate | United States | USD |
| 28 | Becton Dickinson & Co | US0758871091 | 075887109 | 0.663% | $125.9M | Equity (common) | Corporate | United States | USD |
| 29 | Alnylam Pharmaceuticals Inc | US02043Q1076 | 02043Q107 | 0.631% | $119.8M | Equity (common) | Corporate | United States | USD |
| 30 | Agilent Technologies Inc AGILENT TECH INC | US00846U1016 | 00846U101 | 0.608% | $115.4M | Equity (common) | Corporate | United States | USD |
| 31 | Waters Corp | US9418481035 | 941848103 | 0.597% | $113.3M | Equity (common) | Corporate | United States | USD |
| 32 | Humana Inc | US4448591028 | 444859102 | 0.581% | $110.4M | Equity (common) | Corporate | United States | USD |
| 33 | Zoetis Inc | US98978V1035 | 98978V103 | 0.542% | $102.8M | Equity (common) | Corporate | United States | USD |
| 34 | IQVIA Holdings Inc | US46266C1053 | 46266C105 | 0.491% | $93.2M | Equity (common) | Corporate | United States | USD |
| 35 | Natera Inc | US6323071042 | 632307104 | 0.465% | $88.2M | Equity (common) | Corporate | United States | USD |
| 36 | Centene Corp | US15135B1017 | 15135B101 | 0.464% | $88.0M | Equity (common) | Corporate | United States | USD |
| 37 | Dexcom Inc | US2521311074 | 252131107 | 0.455% | $86.4M | Equity (common) | Corporate | United States | USD |
| 38 | Biogen Inc | US09062X1037 | 09062X103 | 0.455% | $86.4M | Equity (common) | Corporate | United States | USD |
| 39 | GE HealthCare Technologies Inc | US36266G1076 | 36266G107 | 0.449% | $85.3M | Equity (common) | Corporate | United States | USD |
| 40 | ResMed Inc | US7611521078 | 761152107 | 0.440% | $83.5M | Equity (common) | Corporate | United States | USD |
| 41 | Veeva Systems Inc VEEVA SYSTEMS-A | US9224751084 | 922475108 | 0.431% | $81.8M | Equity (common) | Corporate | United States | USD |
| 42 | REVOLUTION Medicines Inc | US76155X1000 | 76155X100 | 0.403% | $76.5M | Equity (common) | Corporate | United States | USD |
| 43 | Illumina Inc | US4523271090 | 452327109 | 0.394% | $74.8M | Equity (common) | Corporate | United States | USD |
| 44 | Mettler-Toledo International Inc | US5926881054 | 592688105 | 0.381% | $72.4M | Equity (common) | Corporate | United States | USD |
| 45 | West Pharmaceutical Services Inc | US9553061055 | 955306105 | 0.367% | $69.8M | Equity (common) | Corporate | United States | USD |
| 46 | Insmed Inc | US4576693075 | 457669307 | 0.361% | $68.5M | Equity (common) | Corporate | United States | USD |
| 47 | United Therapeutics Corp | US91307C1027 | 91307C102 | 0.360% | $68.4M | Equity (common) | Corporate | United States | USD |
| 48 | Quest Diagnostics Inc | US74834L1008 | 74834L100 | 0.343% | $65.1M | Equity (common) | Corporate | United States | USD |
| 49 | Labcorp Holdings Inc | US5049221055 | 504922105 | 0.341% | $64.8M | Equity (common) | Corporate | United States | USD |
| 50 | STERIS PLC | IE00BFY8C754 | G8473T100 | 0.330% | $62.7M | Equity (common) | Corporate | United States | USD |
| 51 | Viatris Inc | US92556V1061 | 92556V106 | 0.296% | $56.2M | Equity (common) | Corporate | United States | USD |
| 52 | Zimmer Biomet Holdings Inc | US98956P1021 | 98956P102 | 0.258% | $49.0M | Equity (common) | Corporate | United States | USD |
| 53 | Incyte Corp | US45337C1027 | 45337C102 | 0.255% | $48.5M | Equity (common) | Corporate | United States | USD |
| 54 | Neurocrine Biosciences Inc | US64125C1099 | 64125C109 | 0.250% | $47.4M | Equity (common) | Corporate | United States | USD |
| 55 | Tenet Healthcare Corp | US88033G4073 | 88033G407 | 0.244% | $46.3M | Equity (common) | Corporate | United States | USD |
| 56 | Guardant Health Inc | US40131M1099 | 40131M109 | 0.230% | $43.7M | Equity (common) | Corporate | United States | USD |
| 57 | Moderna Inc | US60770K1079 | 60770K107 | 0.226% | $43.0M | Equity (common) | Corporate | United States | USD |
| 58 | Jazz Pharmaceuticals PLC | IE00B4Q5ZN47 | G50871105 | 0.205% | $38.8M | Equity (common) | Corporate | United States | USD |
| 59 | Exelixis Inc | US30161Q1040 | 30161Q104 | 0.203% | $38.6M | Equity (common) | Corporate | United States | USD |
| 60 | Cooper Cos Inc/The | US2166485019 | 216648501 | 0.190% | $36.0M | Equity (common) | Corporate | United States | USD |
| 61 | Align Technology Inc | US0162551016 | 016255101 | 0.189% | $35.8M | Equity (common) | Corporate | United States | USD |
| 62 | Revvity Inc | US7140461093 | 714046109 | 0.188% | $35.6M | Equity (common) | Corporate | United States | USD |
| 63 | Elanco Animal Health Inc | US28414H1032 | 28414H103 | 0.187% | $35.6M | Equity (common) | Corporate | United States | USD |
| 64 | Penumbra Inc | US70975L1070 | 70975L107 | 0.187% | $35.6M | Equity (common) | Corporate | United States | USD |
| 65 | Ionis Pharmaceuticals Inc | US4622221004 | 462222100 | 0.186% | $35.4M | Equity (common) | Corporate | United States | USD |
| 66 | Solventum Corp | US83444M1018 | 83444M101 | 0.185% | $35.1M | Equity (common) | Corporate | United States | USD |
| 67 | Roivant Sciences Ltd | BMG762791017 | G76279101 | 0.178% | $33.8M | Equity (common) | Corporate | United States | USD |
| 68 | Encompass Health Corp | US29261A1007 | 29261A100 | 0.168% | $32.0M | Equity (common) | Corporate | United States | USD |
| 69 | BioMarin Pharmaceutical Inc | US09061G1013 | 09061G101 | 0.165% | $31.4M | Equity (common) | Corporate | United States | USD |
| 70 | Insulet Corp | US45784P1012 | 45784P101 | 0.161% | $30.6M | Equity (common) | Corporate | United States | USD |
| 71 | Medpace Holdings Inc | US58506Q1094 | 58506Q109 | 0.159% | $30.2M | Equity (common) | Corporate | United States | USD |
| 72 | Vanguard Cmt Funds-Vanguard Market Liquidity Fund Vanguard Market Liquidity Fund | Not reported | Not reported | 0.157% | $29.8M | Short-term investment vehicles (cash funds) | Corporate | United States | USD |
| 73 | Ensign Group Inc/The | US29358P1012 | 29358P101 | 0.154% | $29.2M | Equity (common) | Corporate | United States | USD |
| 74 | Baxter International Inc BAXTER INTL INC | US0718131099 | 071813109 | 0.153% | $29.0M | Equity (common) | Corporate | United States | USD |
| 75 | Bridgebio Pharma Inc | US10806X1028 | 10806X102 | 0.152% | $28.8M | Equity (common) | Corporate | United States | USD |
| 76 | Arrowhead Pharmaceuticals Inc | US04280A1007 | 04280A100 | 0.151% | $28.6M | Equity (common) | Corporate | United States | USD |
| 77 | Medline Inc MEDLINE INC-A | US58507V1070 | 58507V107 | 0.149% | $28.4M | Equity (common) | Corporate | United States | USD |
| 78 | Globus Medical Inc | US3795772082 | 379577208 | 0.145% | $27.6M | Equity (common) | Corporate | United States | USD |
| 79 | Cytokinetics Inc | US23282W6057 | 23282W605 | 0.141% | $26.9M | Equity (common) | Corporate | United States | USD |
| 80 | Molina Healthcare Inc | US60855R1005 | 60855R100 | 0.141% | $26.8M | Equity (common) | Corporate | United States | USD |
| 81 | Charles River Laboratories International Inc | US1598641074 | 159864107 | 0.141% | $26.7M | Equity (common) | Corporate | United States | USD |
| 82 | BrightSpring Health Services Inc | US10950A1060 | 10950A106 | 0.141% | $26.7M | Equity (common) | Corporate | United States | USD |
| 83 | Praxis Precision Medicines Inc | US74006W2070 | 74006W207 | 0.131% | $24.8M | Equity (common) | Corporate | United States | USD |
| 84 | Axsome Therapeutics Inc | US05464T1043 | 05464T104 | 0.130% | $24.7M | Equity (common) | Corporate | United States | USD |
| 85 | Masimo Corp | US5747951003 | 574795100 | 0.129% | $24.5M | Equity (common) | Corporate | United States | USD |
| 86 | Henry Schein Inc | US8064071025 | 806407102 | 0.128% | $24.4M | Equity (common) | Corporate | United States | USD |
| 87 | Universal Health Services Inc UNIVERSAL HLTH-B | US9139031002 | 913903100 | 0.128% | $24.2M | Equity (common) | Corporate | United States | USD |
| 88 | Bio-Techne Corp | US09073M1045 | 09073M104 | 0.127% | $24.2M | Equity (common) | Corporate | United States | USD |
| 89 | Halozyme Therapeutics Inc | US40637H1095 | 40637H109 | 0.124% | $23.5M | Equity (common) | Corporate | United States | USD |
| 90 | DaVita Inc | US23918K1088 | 23918K108 | 0.119% | $22.7M | Equity (common) | Corporate | United States | USD |
| 91 | HealthEquity Inc | US42226A1079 | 42226A107 | 0.119% | $22.6M | Equity (common) | Corporate | United States | USD |
| 92 | Madrigal Pharmaceuticals Inc | US5588681057 | 558868105 | 0.116% | $22.1M | Equity (common) | Corporate | United States | USD |
| 93 | Krystal Biotech Inc | US5011471027 | 501147102 | 0.106% | $20.2M | Equity (common) | Corporate | United States | USD |
| 94 | Repligen Corp | US7599161095 | 759916109 | 0.105% | $19.9M | Equity (common) | Corporate | United States | USD |
| 95 | Alkermes PLC | IE00B56GVS15 | G01767105 | 0.105% | $19.9M | Equity (common) | Corporate | United States | USD |
| 96 | Lantheus Holdings Inc | US5165441032 | 516544103 | 0.104% | $19.8M | Equity (common) | Corporate | United States | USD |
| 97 | Corcept Therapeutics Inc | US2183521028 | 218352102 | 0.104% | $19.8M | Equity (common) | Corporate | United States | USD |
| 98 | Bruker Corp | US1167941087 | 116794108 | 0.099% | $18.9M | Equity (common) | Corporate | United States | USD |
| 99 | Avantor Inc | US05352A1007 | 05352A100 | 0.098% | $18.7M | Equity (common) | Corporate | United States | USD |
| 100 | Vaxcyte Inc | US92243G1085 | 92243G108 | 0.096% | $18.2M | Equity (common) | Corporate | United States | USD |